The facility is located approximately 100 miles outside of Toronto. This facility is where production will commence after installation of the required security measures and subsequent receipt of
Dr Craig McDonald, Professor of Physical Medicine and Rehabilitation at the University of California, Davis, who developed and validated the six-minute walk test as a primary clinical endpoint
This application protects the method of composition and method of use of Prima’s CVac for the generation of a cytotoxic T cell response against the mucin 1 antigen.
The novel cancer vaccine is specifically formulated to target the blood vessels that supply the tumor through induction of tumor autoimmunity and immune stimulation. Batu Biologics scientific research
SYNRIBO is a treatment for adults with chronic myeloid leukemia (CML) who are no longer responding to or are unable to tolerate two or more tyrosine kinase inhibitors
The license includes programs targeting type 2 diabetes (Phase 2b) and cancer cachexia (Phase 2) that Viking is currently preparing to advance into mid-to-late stage clinical trials. Viking
Emerson Ecologics has obtained licenses to distribute prescription and injectable therapy products in 42 states. Emerson also confirmed that they will be submitting applications in the remaining states,
The patent, titled ‘Reduced Size Self-Delivering RNAi Compounds’, broadly covers both the composition and methods of use of RXi’s self-delivering platform technology. The patent, once issued, will be
NCCN ORP vice president Dr Diane Paul said that the ongoing collaboration between the NCCN ORP and Boehringer Ingelheim Pharmaceuticals is a true testament to the advancement of
BioMAP Combo ELECT enables the in vitro testing of drug combinations in the context of human biology for potential safety risks and improved therapeutic effects, thus supporting the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.